Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Can Fite Biopharma Ltd (NYSE American:CANF)

1.81
Delayed Data
As of 6:30pm ET
 +0.07 / +4.02%
Today’s Change
1.24
Today|||52-Week Range
2.19
+22.29%
Year-to-Date
No recent news for Can Fite Biopharma Ltd.

Today’s Trading

Previous close1.74
Today’s open1.77
Day’s range1.77 - 1.84
Volume59,737
Average volume (3 months)62,254
Market cap$29.0M
Data as of 6:30pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)-18.88%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.99%
P/E ratioNM
Price/Sales193.49
Price/Book6.24

Competitors

 Today’s
change
Today’s
% change
BPTHBio Path Holdings In...+0.01+3.90%
APVOAptevo Therapeutics ...+0.24+7.21%
CRMDCorMedix Inc-0.02-3.45%
ICCCImmuCell Corp-0.14-1.88%
Data as of 6:30pm ET, 01/22/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$170.4K
Annual profit (last year)-$6.9M
Net profit margin-4,069.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pnina Fishman
Chief Operating &
Financial Officer
Motti Farbstein
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts